Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status

• Ali Bazarbachi,
• Myriam Labopin,
• Mohamed A. Kharfan-Dabaja,
• Rainer Schwerdtfeger,
• Liisa Volin,
• Jean Henri Bourhis,
• Gérard Socié,
• Etienne Daguindau,
• Tobias Gedde-Dahl,
• Alessandro Rambaldi,
• Michal Karas,
• Günter Schlimok,
• Didier Blaise,
• Patrice Chevallier,
• Florent Malard,
• Christoph Schmid,
• Jordi Esteve,
• Arnon Nagler,
• Mohamad Mohty

Affiliations

Ali Bazarbachi

Department of Internal Medicine, Bone Marrow Transplantation Program, American University of Beirut Medical Center, Beirut

Myriam Labopin

EBMT Paris study office / CEREST-TC, France;Department of Hematology, Saint Antoine Hospital, Paris, France;INSERM UMR 938, Paris, France;Université Pierre et Marie Curie, Paris, France

Mohamed A. Kharfan-Dabaja

Department of Internal Medicine, Bone Marrow Transplantation Program, American University of Beirut Medical Center, Beirut;Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center/University of South Florida College of Medicine, Tampa, Florida

Rainer Schwerdtfeger

Deutsche Klinik für Diagnostik KMT Zentrum, Wiesbaden, Germany

Liisa Volin

Department of Medicine, Helsinki, Finland

Jean Henri Bourhis

Gustave Roussy, institut de cancérologie, BMT Service, Division of Hematology, Department of Medical Oncology, Villejuif, France

Gérard Socié

Hopital St. Louis, Dept.of Hematology – BMT, Paris, France

Etienne Daguindau

Hopital Jean Minjoz, Service d’ Hématologie, Besancon, France

Tobias Gedde-Dahl

Rikshospitalet Department of Medicine, The National Hospital, Oslo, Norway

Alessandro Rambaldi

Azienda Ospedaliera Papa Giovanni XXIII Hematology and Bone Marrow Transplant Unit, Bergamo, Italy

Michal Karas

Charles University Hospital, Dept. of Hematology/Oncology, Pilsen, Czech Republic

Günter Schlimok

Klinikum Augsburg II Medizinische Klinik, Augsburg, Germany

Didier Blaise

Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France

Patrice Chevallier

CHU Nantes Dept. D’Hématologie, Nantes, France;

Florent Malard

EBMT Paris study office / CEREST-TC, France;Department of Hematology, Saint Antoine Hospital, Paris, France;INSERM UMR 938, Paris, France;Université Pierre et Marie Curie, Paris, France

Christoph Schmid

SCT Unit, Klinikum Augsburg, Germany;

Jordi Esteve

Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain

Arnon Nagler

EBMT Paris study office / CEREST-TC, France;Tel Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Israel

Mohamad Mohty

EBMT Paris study office / CEREST-TC, France;Department of Hematology, Saint Antoine Hospital, Paris, France;INSERM UMR 938, Paris, France;Université Pierre et Marie Curie, Paris, France